Navigation Links
New Cancer Therapy That can Be Less Painful

Australian researchers say they have developed a technique to attack and destroy tumours without causing such painful side effects such as nausea or hair loss.

They have used nanotechnology to create tiny particles which specifically attack cancer cells, but leave healthy tissue unaffected.

The particles - or mini-cells - are tagged with anti-cancer antibodies so they zero in on their target.

Traditional chemotherapy typically involves subjecting the patient's entire body to powerful drugs, which can cause a range of severe side-effects.

The new research features in the journal Cancer Cell. Researcher Jennifer MacDiarmid, from Sydney-based biotechnology company EnGeneIC, said: "There is no other system where you can get so much drug concentrated into a little parcel."

In tests, the technique reduced tumours in animals without side effects - and by using only a very small amount of drug.

The mini-cells - about one-fifth the size of a normal cell -were created from bacteria cells stripped of their reproductive powers.

They were then loaded with cancer drugs, and tagged with antibodies which are attracted to cancerous tumours.

Once the cell reaches the cancer, the drug is released directly into the malignant growth.

It is hoped the technique could treat tumours in the breast, ovaries, colon and lungs.

So far it has been used in mice and dogs, and the researchers plan to begin human trials shortly.

Dr MacDiarmid said the treatment could potentially be used on any solid tumours.

She said the technique potentially paved the way for customised drug cocktails for individual patients.

Professor Quentin Pankhurst, of the London Centre for Nanotechnology, said: "The concept of targeted drug delivery is something which has been around for a while and there are many different avenues that have been tested.

"This one looks l ike an interesting and promising one.

"I particularly like the fact that these mini-cells, as they call them, seem to be swallowed up by the cancer cells and taken inside the cancer cells, because that is inherently a very powerful way to actually deliver the drug - actually into the cell."


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2017)... Freedom, PA (PRWEB) , ... April 22, 2017 ... ... healthcare experience to his role as Vice President of Sales and Business Development ... of key GPO/IDN business partner engagements, business development, and strategic planning for the ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce ... the 2017 London Marathon. Set to take place on April 23rd, the London Marathon has ... Schwartz will run as part of team EMPOWER, raising money for the international charity, Smile ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of ... with the 2017 Ruth Ravich Patient Advocacy Award in recognition of her ... was honored with the award at The Beryl Institute’s annual Patient Experience Conference ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
Breaking Medicine Technology: